SMEDDS incorporated polymer matrix: A floating dosage form solution for drugs with poor gastric solubility - Pharmaceutical Technology

Latest Issue

Latest Issue
PharmTech Europe

SMEDDS incorporated polymer matrix: A floating dosage form solution for drugs with poor gastric solubility

Pharmaceutical Technology Europe
Volume 22, Issue 3

Furosemide (FUR) is a high-loop diuretic widely used for the treatment of conditions leading to excessive accumulation of water in the body (edema), which are normally associated with cardiovascular disorders such as heart failure, infarction and hypertension. It has been reported that FUR has a bioavailability problem and initially shows an adverse temporary peak diuretic effect.1,2 To eliminate this, various efforts have been made to develop prolonged-release forms of FUR; however, it has been reported that the bioavailability of such preparations decreases to 40–60% compared with conventional tablet forms.1

OJO Images/Getty Images
Although it has not been demonstrated for humans, animal studies of bioavailability have shown that there may be regions in the stomach and/or the upper part of the small intestine where FUR is specifically absorbed; the short stay of controlled release preparations in this specific region of absorption leads to bioavailability problems.3 Accordingly, developing a floating dosage form with a controlled release pattern aimed at prolonging the residence of FUR at the site of maximum absorption (upper gastro intestinal tract (GIT)) has been proposed as an option for improving bioavailability and, at the same time, reducing the side effect of peak diuresis associated with conventional formulations.4 However, formulating a gastro-retentive dosage form of FUR poses a great challenge because of FUR's insufficient aqueous solubility in acidic mediums (pH 1.2), which may be considered the rate-limiting step in the absorption process.5,6

The present work was conducted to develop a novel floating dosage form of FUR to enhance its solubility by formulating a self microemulsifying drug delivery system (SMEDDS) of FUR, followed by its adsorption onto a mixture of high functionality excipient (SMCC), matrix forming polymers (HPMC K4M and HPMC E50 LV) and a gas-generating agent (NaHCO3) to achieve a buoyant matrix with a controlled release profile.

Materials and methods


FUR was obtained from Aarti drugs (India). The following materials were donated by Gattefosse (India) and were used as received: Labrafac CM10 (C8‑C10 polyglycolized glycerides), Masine 35-1 (Glyceryl momolinoleate), Lauroglycol FCC (Propylene glycol laurate), Labrafil 1944 CS (Apricot kernel oil PEG 6 esters) and Labrafac PG (Propylene glycol caprylate/caprate). Cremophor RH 40 (Polyoxyl 40 Hydrogenated castor oil), Cremophor EL (polyethoxylated castor oil) and Solutol HS 15 (Polyoxyethylene esters of 12-hydroxystearic acid) were obtained from BASF (India). Gelucire 44/14 (PEG‑32 glyceryl laurate), 50/13 (PEG‑32 glyceryl palmistearate) and Triacetin (glyceryl triacetate) were received from Colorcon Asia (India). Span 20 (sorbitan monolaurate), Tween 80 (polyoxyethylene sorbitan mono-oleate), PEG 400 and sodium bicarbonate were bought from Merck Co (India). Silicised microscrystalline cellulose ProSolv SMCC was received from DMV International (India). Grades of hydroxypropyl methylcellulose (HPMC K4M and HPMC E50 LV) were received as gift samples from Colorcon Asia. Deionised water was prepared using a Milli‑Q purification system from Millipore (France).

Acetonitrile and methanol used in the study were of HPLC grade. All other chemicals were reagent grade. Empty hard gelatin capsule shells were donated by ACG capsules (India).

Solubility studies

The solubility of FUR in various components (oils, surfactants and cosurfactants) was determined and 500 mg of each of the selected vehicles were added to each cap vial containing an excess of FUR (1 g). After sealing, the mixture was heated at 40 C in a water bath to facilitate solubilisation. Mixing of the systems was conducted using a vortex mixer and the formed suspensions were then shaken with a shaker at 25 C for 48 h. After reaching equilibrium, each vial was centrifuged at 3000 rpm for 5 min and excess insoluble FUR was discarded by filtration using a membrane filter (0.45 m, 13 mm; Whatman, USA). The concentration of FUR was then quantified using HPLC.

Pseudo-ternary phase diagram

The pseudo‑ternary phase diagrams of oil, surfactant/cosurfactant (S/CoS) and water were developed using the water titration method; the mixtures of oil and S/CoS at certain weight ratios were diluted with water in a dropwise manner. For each phase, diagrams at a specific ratio of S/CoS, 1:1 and 3:1 (w/w), a transparent and homogenous mixture of oil and S/CoS was formed under the mixing by vortexing for 5 min. Each mixture was then titrated with water and visually observed for phase clarity and flowability. The concentrations of water at which turbidity‑to‑transparency and transparency‑to‑turbidity transitions occurred were derived from the weight measurements, and these values were then used to determine the boundaries of the microemulsion domain, corresponding to the chosen value of oils, as well as the S/CoS mixing ratio. The effect of adding triacetin to oil phase‑on‑phase behaviour of the mixture was also studied. To determine the effect of drug addition on microemulsion boundary, phase diagrams were also constructed in drug presence, wherein the oil component was enriched with the drug. Phase diagrams were then constructed using Tri plot v1‑4 software.7

Preparation of SMEDDS

Table 1: SMEDDS formulations.
SMEDDS were prepared using Tween 80 and PEG 400 as the S/CoS combination, and Labrafac Hydro WL (with 40% triacetin) as the oil component (Table 1). In all formulations, the level of FUR was kept constant (10% (w/w) of the total formulation weight). Briefly, accurately weighed FUR was placed in a glass vial followed by the addition of oil and S/CoS, and the components were then mixed by gentle stirring and vortex mixing, and heated at 40 C using a magnetic stirrer until the FUR was perfectly dissolved. The formulations were then subjected to three to four freeze thaw cycles, which included freezing at –4 C for 24 h, followed by thawing at 40 C for 24 h. The formulations were then observed for phase separation. Only formulations that were stable to phase separation were selected for further studies.

Emulsion droplet size analysis

SMEDDS formulation (100 l) was diluted to 250 mL in a beaker and gently mixed using a glass rod. The resultant emulsion was then subjected to particle size analysis, using a Malvern Meta‑sizer equipped with 2000 Hydro MU (Malvern, India] with a particle size measurement range of 0.02–2000 m. Particle size was calculated from the volume size distribution and all studies were repeated in triplicate, with good agreement being found between measurements.

Assessment of self emulsification

The evaluation of self‑emulsifying properties was conducted using visual assessment, as previously reported.8 In brief, visual assessment was performed by drop‑wise addition of the preconcentrate (SMEDDS) into 250 mL distilled water. This was done in a glass beaker at room temperature and the contents were gently stirred magnetically at approximately 100 rpm. Compositions were then categorised on speed of emulsification, clarity and apparent stability of the resultant emulsion.

In vitro dissolution studies

The quantitative in vitro release test was performed in 900 mL of buffer pH 1.2, using USP XXIII Type 1 apparatus, at 37 +/- 0.5 C. The basket shafts were rotated at 50 rpm. The SMEDDS formulation was filled in hard gelatin capsules (1 size) and used for drug release studies to compared with plain FUR. During the release studies, 5 mL sample of medium was taken out and subjected to drug analysis using HPLC. The removed volume was replaced each time with fresh buffer pH 1.2. For determining the in vitro dissolution of plain FUR, the medium was changed to 900 mL of buffer pH 1.2 with Tween 80 (equivalent to the amount used in formulation). Similarly, dissolution studies were also conducted in other mediums (buffer pH 4.5 and 7.2) to observe the effect of pH on drug release.

HPLC analysis of FUR

FUR concentration in the samples was determined by HPLC analysis. The HPLC analysis system consisted of Jasco PU 980 Intelligent pump (Jasco Pumps, India) and Jasco MD‑2015 plus multi‑wavelength detector. The chromatographic column was a C‑18 Lichrosphere 10RP-18e (5 m) 4.6 mm x 250 mm (Merck, India). The chromatographic conditions were:

  • mobile phase: methanol: 0.01 M KH2PO4 (37:63)
  • flow rate: 1 mL/min; loop size: 100 L
  • detection at 274 nm and retention time 9.0 +/- 9.5 min.

The validation parameters were:

  • linearity (range = 5–30 g/mL, coefficient of correlation = 0.9999)
  • limit of detection = 126 ng/mL
  • limit of quantification = 420 ng/mL.


blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
| Weekly

FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy
Clusters set to benefit from improved funding climate but IP rights are even more critical
Supplier Audit Program Marks Progress
FDA, Drug Companies Struggle with Compassionate Use Requests
Source: Pharmaceutical Technology Europe,
Click here